Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2004
09/16/2004WO2004078988A1 Process for production of aromatic diols
09/16/2004WO2004078799A1 Hexadentate ligand and catalytic complex therewith
09/16/2004WO2004078748A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
09/16/2004WO2004078747A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
09/16/2004WO2004078746A2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
09/16/2004WO2004078729A1 Process for the production of substituted nicotinic acid esters
09/16/2004WO2004078728A1 NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS
09/16/2004WO2004078727A1 Novel 6-fluoroalkyl-2(1h)-pyridinones and 6-fluoro- alkylpyridines and processes for the production thereof
09/16/2004WO2004078726A1 Preparation of 3,6-dichloro-2-trichloromethylpyridine by vapor phase chlorination of 6-chloro-2-trichlormethylpyridine
09/16/2004WO2004078725A1 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters
09/16/2004WO2004078724A1 Method of labeling phosphorylated peptide, method of selective adsorption therefor, complex compound for use therein, process for producing the complex compound and starting compound of the complex compound
09/16/2004WO2004078723A1 Novel compound having 4-pyridylalkylthio group as substituent
09/16/2004WO2004078345A1 Method for producing bisphenol catalysts and bisphenols
09/16/2004WO2004078136A2 Pyridinium salts, compounds and methods of use
09/16/2004WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
09/16/2004WO2004071445A3 2-(aminomethyl)arylamide analgesics
09/16/2004WO2004065359A3 Process for the preparation of 2-aminomethylpyridine derivative
09/16/2004WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/16/2004WO2004058712A3 Herbicidally active nicotinoyl derivates
09/16/2004WO2004056178A3 Compounds useful as pesticides
09/16/2004WO2004047739A3 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
09/16/2004WO2004019889A3 Inhibitors of post-amadori advanced glycation end products
09/16/2004WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
09/16/2004US20040181075 Process of making chalcone derivatives
09/16/2004US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/16/2004US20040181067 Tri(cyclo) substituted amide compounds
09/16/2004US20040181058 intermediates for preparing active compounds in medicaments selected from the group consisting of serotonin or noradrenaline uptake inhibitors
09/16/2004US20040180964 anti-obestic activity; Neuropeptide Y antagonist
09/16/2004US20040180940 Substituted anilide ligands for the thyroid receptor
09/16/2004US20040180939 Acetyl 2-hydroxy-1, 3-diaminoalkanes
09/16/2004US20040180938 More preferred compound is (1Z,3E)-1-methyl-1-(4-carboxyphenyl)-2-methoxycarbonyl-3-(2-methylpyridin-4-yl)aminocarbonyl-4-(3-methoxyphenyl)butadiene; for the treatment of acute coronary symptoms
09/16/2004US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable
09/16/2004US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation
09/16/2004US20040180871 Anti-inflammatory compositions and methods
09/16/2004US20040180778 Product of such as 2,6-diacetylpyridine and 4,4'-methylenebis(2,6-dimethylaniline); ethylene selectivity; synthesis, metal complexing, solution polymerization
09/16/2004CA2517461A1 Pyridinium salts, compounds and methods of use
09/16/2004CA2517362A1 Hexadentate ligand and catalytic complex therewith
09/16/2004CA2517083A1 Novel aminopyridine derivatives as mglur5 antagonists
09/16/2004CA2516931A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
09/16/2004CA2516624A1 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
09/15/2004EP1457205A1 Angiogenesis inhibitor
09/15/2004EP1457199A1 Coupling agents having a 2,3,5-triaminopyridine structure and their use for dyeing keratinic fibres
09/15/2004EP1456175A1 Substituted heterocyclic carboxamides with antithrombotic activity
09/15/2004EP1456174A1 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
09/15/2004EP1455790A1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
09/15/2004EP1455786A1 Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith
09/15/2004EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
09/15/2004EP1295878B1 Pyrazinone derivatives
09/15/2004EP1294693B1 Hydroxypyridone methide azo dyes
09/15/2004EP1000932B1 Aromatic ring derivatives
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/15/2004CN1529699A Novel sulfonic acid derivatives
09/15/2004CN1529695A Anthranilic acid amides with heteroarylsulfonyl side chain, method for production thereof, use thereof as medicament or diagnostic agent and phamaceutical preparations containing same
09/15/2004CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments
09/15/2004CN1166643C 4-phenyl-pyrimidine derivatives
09/15/2004CN1166641C New cycloheplene compound, its preparation method and medicine composition containing same
09/15/2004CN1166632C New hydroxamic acid compounds, their preparation method and medicine composition containing them
09/15/2004CN1166626C Position 3 or 4 substituted phenyl compound, its preparing process and its application
09/15/2004CN1166622C 2-amino-1, 2-hydrindene as selective dopamine D3 ligands
09/15/2004CN1166618C New selective retinoid agonists
09/14/2004US6790978 Thyromimetic organic compounds
09/14/2004US6790973 Reduction of ketone to alcohol using complex catalyst
09/14/2004US6790866 Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient
09/14/2004US6790834 Cytostatic agents
09/14/2004CA2280708C Cetp activity inhibitors
09/14/2004CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines
09/10/2004WO2004076434A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076433A1 Dipeptidyl peptidase inhibitors
09/10/2004WO2004076429A1 Ethynyl derivatives serving as factor xa inhibitors
09/10/2004WO2004076421A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
09/10/2004WO2004076420A1 Heteroarylcarbamoylbenzene derivative
09/10/2004WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004WO2004076402A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments
09/10/2004WO2004075864A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/10/2004WO2004056727A8 Process of making chalcone derivatives
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/10/2004WO2004043392B1 Mucin synthesis inhibitors
09/10/2004WO2004035737A3 Heterocyclic selective androgen receptor modulators and methods of use thereof
09/10/2004WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives
09/10/2004WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids
09/10/2004WO2004009034A3 Thiomolybdate analogues and uses thereof
09/10/2004WO2003079984A3 Substituted tetracycline compounds
09/10/2004CA2517391A1 Ethynyl derivatives serving as factor xa inhibitors
09/10/2004CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors
09/10/2004CA2516626A1 Arylcycloalkyl derivatives with branched side chains as ppar receptor modulators, method for their production and their use as medicaments
09/10/2004CA2516407A1 Heteroarylcarbamoylbenzene derivatives
09/09/2004US20040176618 high stereoselectivity; mannitol and tartaric acid starting materials, hydrogenation of ketones, imines, and olefins; 1,2((2,2',5,5'-tetramethyl, 3,3',4,4'-tetrahydroxy) bisphospholane)benzene.
09/09/2004US20040176615 Forming calcium salt from ester
09/09/2004US20040176607 Preparation of 3,6-dichloro-2-trichloromethylpyridine by vapor phase chlorination of 6-chloro-2-trichloromethylpyridine
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176593 Cyclic diamine compounds used as drugs and chemical intermediates
09/09/2004US20040176462 NPY Y5 antagonist
09/09/2004US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
09/09/2004US20040176443 Capsaicin receptor ligands
09/09/2004US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
09/09/2004US20040176419 particularly chronic obstructive pulmonary disease (COPD), asthma or a related pulmonary disease such as chronic bronchitis or allergic rhinitis
09/09/2004US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
09/09/2004US20040176386 Compounds
09/09/2004US20040176384 inhibit Tissue factor expression and vascular permeability factor expression in cancer cells and in vascular endothelial cells in the tumor microenvironment; low toxicity to normal vascular endothelial cells
09/09/2004US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants